ScholarIQanswers from OpenAlex & ORCID
Mansoor Husain
ResearcherPublications, citations & collaboration network
Mansoor Husain is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mansoor Husain have?
ScholarIQindexed works
Mansoor Husain has 302 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mansoor Husain have?
ScholarIQcitation count
Mansoor Husain has 17,973 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mansoor Husain?
ScholarIQh-index
Mansoor Husain has an h-index of 59 in OpenAlex.
What is the i10-index of Mansoor Husain?
ScholarIQi10-index
Mansoor Husain has an i10-index of 134 in OpenAlex.
What is the ORCID of Mansoor Husain?
ScholarIQorcid
The ORCID for Mansoor Husain is on the source record.
What is the OpenAlex record for Mansoor Husain?
ScholarIQopenalex
The OpenAlex for Mansoor Husain is on the source record.
What are the most-cited papers on Mansoor Husain?
ScholarIQmost cited works
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G. Eliaschewitz, Denise Reis Franco, Ole Kleist Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D. Pedersen, Cees J. Tack, Mette S. Thomsen, Tina Vilsbøll, Mark Warren, Stephen C. Bain
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Hiddo J.L. Heerspink, Bruce A. Perkins, David Fitchett, Mansoor Husain, David Z.I. Cherney
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Patrick R. Lawler, Ewan C. Goligher, Jeffrey S. Berger, Matthew D. Neal, Bryan J. McVerry, José Carlos Nicolau, Michelle N Gong, Marc Carrier, Robert S Rosenson, Harmony R. Reynolds, Alexis F Turgeon, Jorge Escobedo, David T. Huang, Charlotte Bradbury, Brett L. Houston, Lucy Z. Kornblith, Anand Kumar, Susan R. Kahn, Mary Cushman, Zoe McQuilten, Arthur S. Slutsky, Keri S. Kim, Anthony Gordon, Bridget‐Anne Kirwan, Maria M. Brooks, Alisa M. Higgins, R Lewis, Elizabeth Lorenzi, Scott M. Berry, Lindsay R. Berry, Aaron W. Aday, Farah Al-Beidh, Djillali Annane, Arabi Y, Diptesh Aryal, Lisa Baumann Kreuziger, Abi Beane, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc Bonten, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Lana A Castellucci, Sweta Chekuri, Jen‐Ting Chen, Allen C Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Todd W. Costantini, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Lise J Estcourt, Brendan M. Everett, Dean Fergusson, Mark Fitzgerald, Robert A Fowler, Jean Philippe GALANAUD, Benjamin Galen, Sheetal Gandotra, Sebastian García-Madrona, Timothy D. Girard, Lucas C. Godoy, Andrew L. Goodman, Herman Goossens, Cameron Green, Yonatan Greenstein, P Groß, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hegde, Carolyn M. Hendrickson, R. Duncan Hite, Alexander Hindenburg, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Kristin Hudock, Beverley J. Hunt, Mansoor Husain, Robert C Hyzy, Vivek Iyer, Jeffrey R. Jacobson, Devachandran Jayakumar, Norma Keller, Akram Khan, Yuri Kim, Andrei Kindzelski, Andrew J. King
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
Michael E. Nassif, Sheryl L. Windsor, Fengming Tang, Yevgeniy Khariton, Mansoor Husain, Silvio E. Inzucchi, Darren K. McGuire, Bertram Pitt, Benjamin M. Scirica, Bethany A. Austin, Mark H. Drazner, Michael Fong, Michael M. Givertz, Robert Gordon, Rita Jermyn, Stuart D. Katz, Sumant Lamba, David E. Lanfear, Shane LaRue, JoAnn Lindenfeld, Michael Malone, Kenneth B. Margulies, Robert J. Mentz, R. Kannan Mutharasan, Michael Pursley, Guillermo E. Umpierrez, Mikhail Kosiborod, On behalf of the DEFINE-HF Investigators, Ali O. Malik, Nannette Wenger, Modele O. Ogunniyi, Priyathama Vellanki, Brenda Murphy, Jonathan Newman, Justin Hartupee, Charu Gupta, Marcela Goldsmith, Paramdeep Baweja, Manuel Montero, Stephen S. Gottlieb, Maria Rosa Costanzo, Thanh T. Hoang, Alicia Warnock, Larry A. Allen, W.H. Wilson Tang, Horng H. Chen, John M. Cox
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
Mansoor Husain, Stephen C. Bain, Ole Kleist Jeppesen, Ildiko Lingvay, Rasmus Sørrig, Marianne Bach Treppendahl, Tina Vilsbøll